Eledon Pharmaceuticals Completes Enrollment in Phase 2 BESTOW Trial for Tegoprubart in Kidney Transplantation Ahead of Schedule and Reports Positive Initial Data From Ongoing Trials

Quiver QuantitativeJan 13 07:12 ET

Express News | Eledon Pharmaceuticals: On Track to Report Topline Results in Q4 of 2025

ReutersJan 13 07:03 ET

Press Release: Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Dow JonesJan 13 07:00 ET

Eledon Pharma Analyst Ratings

BenzingaNov 20, 2024 08:16 ET · Ratings

H.C. Wainwright Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsNov 20, 2024 06:31 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Eledon Pharmaceuticals (ELDN)

TipRanksNov 20, 2024 06:20 ET · Ratings